Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing desogestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel + ethinyl estradiol + ethinyl oestradiol 0.15mg/0.01mg/0.01mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Desogestrel + ethinyl oestradiol 0.15mg/0.03mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Desogestrel 75 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing desogestrel and ethinylestradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Desogestrel 150 microgram and ethinylestradiol 25 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Desogestrel 150 microgram and ethinylestradiol 30 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol+desogestrel 20micrograms/150micrograms tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely desogestrel 125 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol+desogestrel 20micrograms/150micrograms tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol+desogestrel 20micrograms/150micrograms tablet (substance) |
Has basis of strength substance (attribute) |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel 150 microgram and ethinylestradiol 30 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel 150 microgram and ethinylestradiol 30 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel + ethinyl oestradiol 0.15mg/0.03mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel + ethinyl oestradiol 0.15mg/0.03mg tablet |
Has basis of strength substance (attribute) |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel 75 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel 75 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Desogestrel 150 microgram and ethinylestradiol 25 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel 150 microgram and ethinylestradiol 25 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely desogestrel 125 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely desogestrel 125 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely desogestrel 125 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel 150 microgram and ethinylestradiol 30 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel 150 microgram and ethinylestradiol 25 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol+desogestrel 20micrograms/150micrograms tablet (substance) |
Has basis of strength substance (attribute) |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol+desogestrel 20micrograms/150micrograms tablet (substance) |
Has precise active ingredient |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Desogestrel 150 microgram and ethinylestradiol 30 microgram oral tablet |
Has precise active ingredient |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Desogestrel 75 microgram oral tablet |
Has precise active ingredient |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel 150 microgram and ethinylestradiol 25 microgram oral tablet |
Has precise active ingredient |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing desogestrel and ethinylestradiol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing desogestrel in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely desogestrel 125 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Desogestrel and ethinylestradiol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only desogestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only desogestrel and ethinylestradiol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Desogestrel only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Desogestrel |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |